Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Lancet. Oncology|February 14, 2022
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trialDean A Fennell, Amy King, Seid Mohammed, et al.Nature Communications|March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironmentMin Zhang, Jin-Li Luo, Qianqian Sun, et al.The Lancet. Digital Health|August 29, 2022
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19Christos P Kotanidis, Cheng Xie, Donna Alexander, et al.The Lancet. Oncology|June 17, 2026
Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre studyKevin B W Groot Lipman, Rianne Wittenberg, Mateus de Oliveira Taveira, et al.Nature Communications|August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesotheliomaMin Zhang, Aleksandra Bzura, Essa Y Baitei, et al.Pageof 3